TY  - CONF

T1  - A salvage autologous stem cell transplant (ASCT2) induces superior overall survival following bortezomib-containing re-induction therapy for relapsed multiple myeloma (MM): Results from the Myeloma X (Intensive) Trial

JO  - BRITISH JOURNAL OF HAEMATOLOGY

PY  - 2016/04/01

AU  - Cook G

AU  - Williams C

AU  - Cairns DA

AU  - Hockaday A

AU  - Cavenagh JD

AU  - Snowden JA

AU  - Parrish C

AU  - Yong K

AU  - Cavet J

AU  - Hunter H

AU  - Bird JM et al

ED  - 

VL  - 173

SP  - 5

EP  - 6

Y2  - 2024/12/22

ER  -